Co-alterations in PIK3CA & ARID1A lead to enhanced sensitivity to PI3K inhibition
Shirsa Udgata
Advisor: Dustin Deming, MD
Targeting Human Papillomavirus (HPV) Oncoproteins Using HIV Protease Inhibitors
Kerry Smith
Advisor: Nate Sherer, PhD
6571 WIMR II
@ 3:30 pm - 4:30 pm
Co-alterations in PIK3CA & ARID1A lead to enhanced sensitivity to PI3K inhibition
Shirsa Udgata
Advisor: Dustin Deming, MD
Targeting Human Papillomavirus (HPV) Oncoproteins Using HIV Protease Inhibitors
Kerry Smith
Advisor: Nate Sherer, PhD